CUI JINGRONG JEAN (Chief Scientific Officer) sold 6.5% of their position (55.50K shares) of TURNING POINT THERAPEUTICS, INC. on the open market
Open‑market sale worth $3.55M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−9.25K
Price / share
$62.75
Trade value
$580.50K
% of position
Common Stock
Shares
−9.25K
Price / share
$63.14
Trade value
$583.98K
% of position
Common Stock
Shares
−14.25K
Price / share
$63.03
Trade value
$898.18K
% of position
Common Stock
Shares
−4.25K
Price / share
$63.88
Trade value
$271.49K
% of position
Common Stock
Shares
−5.80K
Price / share
$65.31
Trade value
$378.80K
% of position
Common Stock
Shares
−12.40K
Price / share
$66.19
Trade value
$820.76K
% of position
Common Stock
Shares
−300.00
Price / share
$66.80
Trade value
$20.04K
% of position
Net shares
−55.50K
Net value
-$3.55M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/10/2020 | S · Sale | −9.25K | $62.75 | $580.50K | 1.1% | 848.22K | 838.97K |
| Common Stock Indirect | 2/10/2020 | S · Sale | −9.25K | $63.14 | $583.98K | 1.1% | 838.97K | 829.72K |
| Common Stock Indirect | 2/11/2020 | S · Sale | −14.25K | $63.03 | $898.18K | 1.7% | 829.72K | 815.47K |
| Common Stock Indirect | 2/11/2020 | S · Sale | −4.25K | $63.88 | $271.49K | 0.5% | 815.47K | 811.22K |
| Common Stock Indirect | 2/12/2020 | S · Sale | −5.80K | $65.31 | $378.80K | 0.7% | 811.22K | 805.42K |
| Common Stock Indirect | 2/12/2020 | S · Sale | −12.40K | $66.19 | $820.76K | 1.5% | 805.42K | 793.02K |
| Common Stock Indirect | 2/12/2020 | S · Sale | −300.00 | $66.80 | $20.04K | 0.0% | 793.02K | 792.72K |
| Total | −55.50K | -$3.55M | ||||||
Common Stock
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.30M | Direct |
| Total | 1.30M | 1.30M direct |